Vitamin D-induced ectodomain shedding of TNF receptor 1 as a nongenomic action: D3 vs D2 derivatives

Journal of Steroid Biochemistry and Molecular Biology

Volumn 155, Issue , 2016, Pages 18-25

  Yang, Won Seok ^a   Yu, Hoon ^a   Kim, Jin Ju ^b   Lee, Mee Jeong ^c   Park, Su Kil ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Asan Institute for Life Sciences   (South Korea)

^c Dankook University   (South Korea)

Author keywords

1,25 Dihydroxyvitamin D2; 25 Hydroxyvitamin D3; ADAM10; ERp57; L type Ca2+ channel; TNF receptor 1

Indexed keywords

ADAM10 ENDOPEPTIDASE; CALCIFEDIOL; CALCITRIOL; CALCIUM ION; COLECALCIFEROL; DISINTEGRIN; ELOCALCITOL; ERGOCALCIFEROL; PARICALCITOL; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR RECEPTOR 1; VERAPAMIL; VITAMIN D DERIVATIVE; VITAMIN D RECEPTOR; 1,25-DIHYDROXYERGOCALCIFEROL; ADAM PROTEIN; ADAM10 PROTEIN, HUMAN; CALCITRIOL RECEPTOR; CALCIUM; CALCIUM CHANNEL L TYPE; DIHYDROXY-VITAMIN D3; MEMBRANE PROTEIN; PDIA3 PROTEIN, HUMAN; PROTEIN DISULFIDE ISOMERASE; SECRETASE; VITAMIN D;

ARTICLE; CALCIUM CELL LEVEL; CELL MEMBRANE; CELL SURFACE; CONTROLLED STUDY; ECTODOMAIN SHEDDING; ENDOPLASMIC RETICULUM STRESS; HUMAN; HUMAN CELL; PROTEIN METABOLISM; SMOOTH MUSCLE FIBER; ANALOGS AND DERIVATIVES; CELL CULTURE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; GENETICS; METABOLISM; PROTEIN TERTIARY STRUCTURE; VASCULAR SMOOTH MUSCLE;

ADAM PROTEINS; AMYLOID PRECURSOR PROTEIN SECRETASES; CALCITRIOL; CALCIUM; CALCIUM CHANNELS, L-TYPE; CELLS, CULTURED; CHOLECALCIFEROL; ERGOCALCIFEROLS; HUMANS; MEMBRANE PROTEINS; MUSCLE, SMOOTH, VASCULAR; PROTEIN DISULFIDE-ISOMERASES; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CALCITRIOL; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; VITAMIN D;

EID: 84942925705     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2015.09.019     Document Type: Article

References (43)

1. H.F. DeLuca Overview of general physiologic features and functions of vitamin D Am. J. Clin. Nutr. 80 6 Suppl 2004 1689S 1696S
2. J. Vojinovic Vitamin D receptor agonists' anti-inflammatory properties Ann. N. Y. Acad. Sci. 1317 2014 47 56 10.1111/nyas.12429
3. D.D. Bikle Vitamin D metabolism, mechanism of action, and clinical applications Chem. Biol. 21 2014 319 329 10.1016/j.chembiol.2013.12.016
4. 3: genomic and non-genomic mechanisms Best Pract. Res. Clin. Endocrinol. Metab. 25 2011 543 559 10.1016/j.beem.2011.05.010
5. M. Blomberg Jensen, and S. Dissing Non-genomic effects of vitamin D in human spermatozoa Steroids 77 2012 903 909 10.1016/j.steroids.2012.02.020
6. 3-MARRS protein: contribution to steroid stimulated calcium uptake in chicks and rats Steroids 70 2005 455 457
7. 3 causes ADAM10-dependent ectodomain shedding of TNF receptor 1 in vascular smooth muscle cells Mol. Pharmacol. 87 2015 533 542 10.1124/mol.114.097147
8. M. Peacock Calcium metabolism in health and disease Clin. J. Am. Soc. Nephrol. 5 Suppl. 1 2010 S23 S30 10.2215/CJN.05910809
9. S.M. Sprague, and D. Coyne Control of secondary hyperparathyroidism by vitamin D receptor agonists in chronic kidney disease Clin. J. Am. Soc. Nephrol. 5 2010 512 518 10.2215/CJN.03850609
10. I. Kremer, and D. Bolivar Influence of calcium and 1,25-dihydroxycholecalciferol on proliferation and proto-oncogene expression in primary cultures of bovine parathyroid cells Endocrinology 125 1989 935 941
11. J. Silver, J. Russell, and L.M. Sherwood Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells Proc. Natl. Acad. Sci. U. S. A. 82 1985 4270 4273
12. K.J. Martin, and E.A. González Vitamin D analogues for the management of secondary hyperparathyroidism Am. J. Kidney Dis. 38 5 Suppl. 5 2001 S34 40
13. C. Crescioli, P. Ferruzzi, A. Caporali, R. Mancina, A. Comerci, M. Muratori, M. Scaltriti, G.B. Vannelli, S. Smiroldo, R. Mariani, D. Villari, S. Bettuzzi, M. Serio, L. Adorini, and M. Maggi Inhibition of spontaneous and androgen-induced prostate growth by a nonhypercalcemic calcitriol analog Endocrinology 144 2003 3046 3057
14. 2, and its 24 epimer Arch. Biochem. Biophys. 273 1989 64 71
15. 2 Am. J. Physiol. 254 1988 E402 406
16. 3, and vitamin D analogs Annu. Rev. Nutr. 33 2013 23 44
17. Z. Al-Aly, R.A. Qazi, E.A. González, A. Zeringue, and K.J. Martin Changes in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD Am. J. Kidney Dis. 50 2007 59 68
18. 2 in hemodialysis patients with moderate to severe secondary hyperparathyroidism Kidney Int. 51 1997 317 323
19. S.M. Moe, A. Saifullah, R.E. LaClair, S.A. Usman, and Z. Yu A randomized trial of cholecalciferol versus doxercalciferol for lowering parathyroid hormone in chronic kidney disease Clin. J. Am. Soc. Nephrol. 5 2010 299 306 10.2215/CJN.07131009
20. D.M. Robinson, and L.J. Scott Paricalcitol: a review of its use in the management of secondary hyperparathyroidism Drugs 65 2005 559 576
21. J. Cheng, W. Zhang, X. Zhang, X. Li, and J. Chen Efficacy and safety of paricalcitol therapy for chronic kidney disease: a meta-analysis Clin. J. Am. Soc. Nephrol. 7 2012 391 400 10.2215/CJN.03000311
22. 3 metabolites on cytosolic free calcium in confluent mouse osteoblasts J. Biol. Chem. 262 1987 13168 13173
23. 3 analogs stimulate calcium currents in rat osteosarcoma cells J. Biol. Chem. 269 1994 23889 23893
24. A. Bhaskaracharya, P.P. Dao-Ung, I. Jalilian, M. Spildrejorde, K.K. Skarratt, S.J. Fuller, R. Sluyter, and L. Stokes Probenecid blocks human P2X7 receptor-induced dye uptake via a pannexin-1 independent mechanism PLoS One 3058 2014 10.1371/journal.pone.0093058
25. E.P. van der Vorst, A.A. Keijbeck, M.P. de Winther, and M.M. Donners A disintegrin and metalloproteases: molecular scissors in angiogenesis, inflammation and atherosclerosis Atherosclerosis 224 2012 302 308 10.1016/j.atherosclerosis.2012.04.023
26. 3 and its analogues in rat osteoblast-like cells Biol. Pharm. Bull. 22 1999 1058 1063
27. 3 J. Biol. Chem. 268 1993 20022 20030
28. 3-26,23-lactone antagonism of hVDRwt gene activation and its switch to a superagonist J. Biol. Chem. 284 2009 36292 36301 10.1074/jbc.M109.042069
29. 3-stimulated uptake of calcium and phosphate in intestinal cells Steroids 77 2012 897 902 10.1016/j.steroids.2012.04.002
30. 3-MARRS receptor: multiple functional roles in diverse cell systems Curr. Med. Chem. 14 2007 1087 1093
31. 3 in rat osteosarcoma cells: structure-function studies using ligand analogs Endocrinology 29 1991 1876 1884
32. D. Menegaz, M.T. Mizwicki, A. Barrientos-Duran, N. Chen, H.L. Henry, and A.W. Norman Vitamin D receptor (VDR) regulation of voltage-gated chloride channels by ligands preferring a VDR-alternative pocket (VDR-AP) Mol. Endocrinol. 25 2011 1289 1300 10.1210/me.2010-0442
33. D. Mizwicki, S. Menegaz, and H.L. Yaghmaei A molecular description of ligand binding to the two overlapping binding pockets of the nuclear vitamin D receptor (VDR): structure-function implications J. Steroid Biochem. Mol. Biol. 121 2010 98 105 10.1016/j.jsbmb.2010.04.005
34. 3-MARRS receptor: multiple functional roles in diverse cell systems Curr. Med. Chem. 14 2007 1087 1093
35. 2+ influx and PKC activation J.Cell Biol. 165 2004 893 902
36. T. Maretzky, A. Evers, S. Le Gall, R.O. Alabi, N. Speck, K. Reiss, and C.P. Blobel The cytoplasmic domain of a disintegrin and metalloproteinase 10 (ADAM10) regulates its constitutive activity but is dispensable for stimulated ADAM10-dependent shedding J. Biol. Chem. 290 2015 7416 7425 10.1074/jbc.M114.603753
37. E. Marcello, F. Gardoni, M. Di Luca, and I. Pérez-Otaño An arginine stretch limits ADAM10 exit from the endoplasmic reticulum J Biol. Chem. 285 2010 10376 10384 10.1074/jbc.M109.055947
38. R. Chowdhury, S. Kunutsor, A. Vitezova, C. Oliver-Williams, S. Chowdhury, J.C. Kiefte-de-Jong, H. Khan, C.P. Baena, D. Prabhakaran, M.B. Hoshen, B.S. Feldman, A. Pan, L. Johnson, F. Crowe, F.B. Hu, and O.H. Franco Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies BMJ 348 2014 g1903 10.1136/bmj.g1903
39. B. Legein, L. Temmerman, E.A. Biessen, and E. Lutgens Inflammation and immune system interactions in atherosclerosis Cell. Mol. Life Sci. 70 2013 3847 3869 10.1007/s00018-013-1289-1
40. P. Kleinbongard, G. Heusch, and R. Schulz TNFα in atherosclerosis, myocardial ischemia/reperfusion and heart failure Pharmacol. Ther. 127 2010 295 314 10.1016/j.pharmthera.2010.05.002
41. S. Dobnig, H. Pilz, W. Scharnagl, U. Renner, B. Seelhorst, J. Wellnitz, B.O. Kinkeldei, and G. Boehm Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality Arch. Intern. Med. 168 2008 1340 1349 10.1001/archinte.168.12.1340
42. E. Giovannucci, Y. Liu, B.W. Hollis, and E.B. Rimm 25-Hydroxyvitamin D and risk of myocardial infarction in men: a prospective study Arch. Intern. Med. 168 2008 1174 1180 10.1001/archinte.168.11.1174
43. K.J. Ryan, Z.C. Daniel, L.J. Craggs, T. Parr, and J.M. Brameld Dose-dependent effects of vitamin D on transdifferentiation of skeletal muscle cells to adipose cells J. Endocrinol. 217 2013 45 58 10.1530/JOE-12-0234